REPL Replimune Group Inc

$REPL Just wait for the next ATM update…shares will start showing dilution and then shareholders start dumping again. It is inevitable.

$REPL $QURE $RGNX For any interested, a WSJ article covering biotech https://www.wsj.com/health/pharma/trump-administration-shift-puts-this-corner-of-biotech-back-in-favor-2abc0ae3?st=MqN8Gs&reflink=desktopwebshare_permalink (gift link) Disclosure: long QURE, RGNX; NFA & GL

$REPL beautiful bounce of key support. Tutes are now gonna make this run after loading up!!! 🚀🚀🚀🚀🚀

$REPL The high institutional ownership is for a reason. There are 10K new eligible participants every year. The regimen is $450K. if only 5K get the medicine per year, this is $2.5B which will make the market valuation $12.5B and the stock price around $100 per share

$REPL This had a good run. Time to transfer it all over to IOVA that is one is strong in the bio-tech with revenue

$REPL we are on track. Take the cheaper shares as a gift. Tutes have loaded. Opportunity of a lifetime. 🚀🚀🚀

$REPL Hope you guys loaded the boat when this retraced to the $12s. Tutes are loaded... don't bet against them. 🚀🚀🚀

$REPL released TUDRIQEV, its first oncolytic therapy, now commercially available in the U.S. for advanced melanoma.

$REPL The company will start shipping its fda approved drug early next week. $500K per patient.

$REPL waiting for this bearish seasonal time period to end, then I plan to load REPL when the time is right...

$REPL | Snapshot 📊🧬 • Business: Replimune Group, Inc., a clinical-stage biotechnology company developing novel oncolytic immunotherapies (RPx platform / RP1) for solid tumors. • Financial Health & Pipeline: Recent positive momentum backed by favorable FDA Advisory Committee votes for RP1 in advanced melanoma.• Bias & Conviction: Bullish Recovery | Moderate Conviction (Testing key channel resistance at $13.00 with unusual near-the-money call positioning). 🎯 Key Levels: 🐂 Bull Trigger: $13.00 / $13.50 🚀 Targets: $15.00 / $16.11 / $18.00 🛡️ Support: $12.82 / $10.00 ⚠️ Risk: $8.15 / $6.00 🔥 Options Flow: • 🟢 09/25/2026 $13.0 Call ($51.6K Opening Block | +0.46% OTM) #REPL #biotech #tech #finance #hovdid

$REPL 137.69% institutional ownership. This is massive. I never seen anything like it. They will make the PPS fly to 60 by the end of next year 2027